ALVOAlvotech
+4.0% today · −37.2% over a year
1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 18% of the instruments we score
Stability: among the weakest; priced higher than most peers (P/E 55.2). No dividend.
Alvotech (ALVO) valuation against sector peers: P/E 55.2 (sector median 22.4), EV/EBIT 34.1, free-cash-flow yield −7.4%, P/S 2.6.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | ALVO | Sector median | vs median |
|---|---|---|---|
| P/E | 55.2 | 22.4 · n=28 | 146% above |
| P/B | — | 3.6 · n=45 | — |
| P/S | 2.6 | 4.5 · n=40 | 41% below |
| EV/EBIT | 34.1 | 20.8 · n=28 | 64% above |
| Free-cash-flow yield | −7.4% | 3.5% · n=41 | 315% below |
| Dividend yield | 0.00% | 0.12% · n=100 | 100% below |
| Return on equity | — | 6.8% · n=56 | — |
| Return on invested capital | 7.0% | 7.0% · n=47 | near the median |
| Gross margin | 59.8% | 70.2% · n=39 | 15% below |
| Net debt / EBITDA | 9.71 | 1.39 · n=26 | 598% above |
Value factor: 27 of 100 within the peer group. Full score breakdown →
Sector peers
The largest companies of the same sector and region.
| NVSNovartis AG | 21.3 | 6.5 | 17.9 | 5.9% | 2.5% | 9/10 |
|---|---|---|---|---|---|---|
| NOVNNovartis AG | 21.2 | 6.4 | 17.8 | 5.9% | 2.9% | 10/10 |
| AZNAstraZeneca plc | 25.7 | 5.4 | 20.9 | 4.5% | 1.9% | 6/10 |
| AZNAstraZeneca PLC | 25.7 | 5.4 | 20.9 | 4.5% | 1.3% | 6/10 |
| NVONovo Nordisk A/S | 11.2 | 5.9 | 9.8 | 5.2% | 4.8% | 7/10 |
| GSKGSK plc | 13.8 | 4.8 | 11.3 | 8.1% | 3.7% | 10/10 |
| SNYSanofi | 11.8 | 1.3 | 16.3 | 7.8% | 5.0% | 7/10 |
| SANSanofi SA | 11.8 | 1.3 | 16.2 | 7.8% | 5.5% | 8/10 |
| TEVATeva Pharmaceutical Industries Limited | 66.0 | 6.0 | 37.2 | 2.9% | 0.0% | 6/10 |
| ALCAlcon | 34.7 | 1.5 | 27.3 | 5.1% | 0.4% | 4/10 |
Fiscal-year history
From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 31 Mar 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.